Medicant composition for the treatment of diabetes

Details Medicant composition for the treatment of diabetes Medicant composition for the treatment of diabetes

1975-02-21

1978-04-04

Rosen, Sam

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

424280, 424321, A61K 31635, A61K 31375, A61K 3118

Patent

active

040828425

ABSTRACT:
An orally administered medicant composition useful for the treatment of diabetes mellitus; whose constituents are a hypoglycemic of the sulphonylurea derivative type together with an anti-bacterial sulfonamide and ascorbic acid. A unit dosage of one preferred formulation is comprised of 0.5 gram tolbutamide, 100 milligrams sulfamethox-pyridazine and 50 milligrams ascorbic acid. A typical treatment that has proven successful in correcting numerous diabetic conditions may begin with as many as six unit dosages the first day, thereafter the dosage is reduced, then sustained at a level in accordance to the response of the patient; treatment is terminated usually after a six month period.

REFERENCES:
patent: 3298917 (1967-01-01), Bicking
Heerd et al - Chem. Abst. vol. 70 (1969) 87843u.
Zymaris - Chem. Abst. vol. 65 (1966) p. 9415f.

Affiliated with

Also associated with

Rating

Medicant composition for the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicant composition for the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicant composition for the treatment of diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-724395